Infoway Marketing nameda reason for the growth of investment attractiveness of Si14 AG shares

Infoway announced an increase in interest in the Pre-IPO of the Swiss holding Si14 AG after the presentation of the holding’s medical projects at the BRICS and BRICS+ International Summit in Dubai. The holding’s announced cooperation with the BRICS and BRICS+ countries stimulated the interest of investors and analysts in Si14 AG in the Pre-IPO market.

Technologies are implemented through the Si14 Pharma direction.Si14 Pharma specializes in homeopathic steroids, innovative medical equipment, Life Packs, and dietary supplements based on metallob atomic colloids..

The company is engaged in the implementation of colloidal technologies in the field of medicine in the BRICS countries. The drugs are based on nanoparticles of magnesium, zinc, copper and silver, which can effectively counteract infections.

The investment attractiveness of Si14 AG shares is growing after the holding introduced patented colloidal nanotechnologies in the pharmaceuticalindustry, according to Infoway Marketing, the official representative of Si14 AGInfoway Marketing.